Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04882306Not ApplicableUnknown

The ABC Study: Assessment of Breast Density Classification

Role: lead

NCT04894955Not ApplicableUnknown

Micrima MARIA Data Collection for Machine Learning Study

Role: lead

NCT03771833Not ApplicableCompleted

M5 vs. M6 Comparison Study With a Sub Study Into the Dielectric Constant of Aspirated Cyst Fluid

Role: lead

NCT02493595Completed

Synthetic Aperture Radar Detection of Breast Tumours

Role: lead

NCT03302819Not ApplicableUnknown

London Investigation Into diElectric Scanning of Lesions

Role: collaborator

All 5 trials loaded